Browsing Over 126 Presentations

Sort By
Antibody-drug conjugate (ADC) technology Educational session

Introduction (ID 35)

Lecture Time
14:00 - 14:05
Speakers
  • Noboru Yamamoto (Chuo-ku, Japan)
Session Name
Antibody-drug conjugate (ADC) technology
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
14:00 - 15:30
Authors
  • Noboru Yamamoto (Chuo-ku, Japan)
Antibody-drug conjugate (ADC) technology Educational session

Clinical development of next generation ADCs (ID 36)

Lecture Time
14:05 - 14:25
Speakers
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Session Name
Antibody-drug conjugate (ADC) technology
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
14:00 - 15:30
Antibody-drug conjugate (ADC) technology Educational session

Re-positioning the payload (ID 37)

Lecture Time
14:25 - 14:45
Speakers
  • Noboru Yamamoto (Chuo-ku, Japan)
Session Name
Antibody-drug conjugate (ADC) technology
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
14:00 - 15:30
Antibody-drug conjugate (ADC) technology Educational session

ADCs and new targets in solid tumours (ID 38)

Lecture Time
14:45 - 15:05
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Session Name
Antibody-drug conjugate (ADC) technology
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
14:00 - 15:30
Antibody-drug conjugate (ADC) technology Educational session

Development of immune ADCs (ID 39)

Lecture Time
15:05 - 15:25
Speakers
  • Shelly Ackerman (Redwood City, United States of America)
Session Name
Antibody-drug conjugate (ADC) technology
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
14:00 - 15:30
Authors
  • Shelly Ackerman (Redwood City, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Conclusions (ID 40)

Lecture Time
15:25 - 15:30
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Session Name
Antibody-drug conjugate (ADC) technology
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
14:00 - 15:30
Authors
  • Giuseppe Curigliano (Milan, Italy)
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment Meet the professor

Epidemiology of NTRK gene fusion: Clinical case presentation and present results (ID 139)

Lecture Time
13:00 - 13:20
Speakers
  • Ulrik Lassen (Copenhagen, Denmark)
Session Name
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment
Location
Room 342A, Palais des Congrès de Paris, Paris, France
Date
Mon, 02.03.2020
Time
13:00 - 14:00
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment Meet the professor

NTRK Testing: The ESMO Precision Medicine recommendation (ID 140)

Lecture Time
13:20 - 13:35
Speakers
  • Caterina Marchiò (Candiolo, Italy)
Session Name
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment
Location
Room 342A, Palais des Congrès de Paris, Paris, France
Date
Mon, 02.03.2020
Time
13:00 - 14:00
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment Meet the professor

The Growth Modulation Index (GMI): A new way to evaluate NTRK inhibitors compared with previous treatment lines (ID 141)

Lecture Time
13:35 - 13:50
Speakers
  • Antoine Italiano (Bordeaux, CEDEX, France)
Session Name
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment
Location
Room 342A, Palais des Congrès de Paris, Paris, France
Date
Mon, 02.03.2020
Time
13:00 - 14:00
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment Meet the professor

Q&A / Discussion (ID 142)

Lecture Time
13:50 - 14:00
Session Name
Bayer - Meet the professor: NTRK Fusion Cancer: Treatment with NTRK inhibitors and NTRK testing to identify patients who could benefit from treatment
Location
Room 342A, Palais des Congrès de Paris, Paris, France
Date
Mon, 02.03.2020
Time
13:00 - 14:00
Best Poster session Abstract related session

Q&A (ID 265)

Lecture Time
17:40 - 17:45
Session Name
Best Poster session
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
17:30 - 18:00
Best Poster session Abstract related session

Q&A (ID 266)

Lecture Time
17:50 - 17:55
Session Name
Best Poster session
Location
Amphitheatre Bordeaux, Palais des Congrès de Paris, Paris, France
Date
Tue, 03.03.2020
Time
17:30 - 18:00